Viewing Study NCT06499350


Ignite Creation Date: 2025-12-24 @ 4:52 PM
Ignite Modification Date: 2026-01-19 @ 10:15 PM
Study NCT ID: NCT06499350
Status: RECRUITING
Last Update Posted: 2025-08-07
First Post: 2024-07-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of FC084CSA in Combination of Tislelizumab in Patients With Advanced Malignant Solid Tumors
Sponsor: FindCure Biosciences (ZhongShan) Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module